Refers individuals to appropriate service providers that are able to provide services to such individual within seventy-two hours for substance use disorders.
S 3029 establishes a licensing system for genetic counselors in New York and creates a State Board for Genetic Counseling. To practice as a genetic counselor or use the title "genetic counselor," individuals must obtain a license by meeting requirements including a master's degree in genetic counseling, passing an exam, and demonstrating relevant experience. The bill prohibits unlicensed practice and restricts the title to licensed professionals, while defining genetic counseling as providing education about genetic risks and testing - without diagnosing or treating medical conditions. The State Board, composed of five licensed genetic counselors, one physician, and one public representative, will oversee licensing standards and professional conduct. This directly affects genetic counselors seeking to practice in New York and ensures consistent educational and professional standards for the public.
Relates to program eligibility for plans comparable to Medicare part D; provides for analysis of health plans by the department of health to determine whether such health plans meet or exceed the Medicare part D standard; requires the department of health, in consultation with the department of financial services, to notify prescription drug insurers of the provisions of this act.
Establishes a specialized health home program to serve certain individuals with physical disabilities who are Medicaid eligible adults eighteen years of age or older with a diagnosis of a neurological, muscular, or neuromuscular condition, and a mobility impairment; provides that a specialized health home shall be reimbursed on a fee-for-service basis and shall receive enhanced rates of payment; makes related provisions.
Includes Lyme disease and other tick-borne diseases as occupational diseases for purposes of workers' compensation; clarifies that disability includes disability caused by Lyme disease or other tick-borne diseases; requires insurance coverage of long term medical care for Lyme disease and other tick borne diseases.
Requires disclosure of information concerning non-invasive prenatal screening for chromosomal abnormalities including the benefits and limitations of non-invasive prenatal testing, the difference between non-invasive prenatal testing and prenatal diagnostic testing, and current recommendations from the American College of Obstetricians and Gynecologists (ACOG), the Society for Maternal Fetal Medicine, and the American College of Medical Genetics and Genomics (ACMG).
Enacts the "public university emergency contraception education act" requiring public universities to develop, produce and distribute informational materials related to emergency contraception.
This bill creates a certification process for organizations providing in-home substance use disorder treatment services in New York. It requires applicants (including out-of-state entities registered with the state) to meet specific clinical standards, including conducting screenings for overdose risk, mental health conditions, and suicide risk. Certified providers must implement safety plans, medication-assisted treatment, naloxone access, and regular recovery planning. The law aims to standardize and expand access to in-home treatment while ensuring providers meet defined safety and clinical requirements.
Provides practical support for access to abortion care including, but not limited to, reimbursement for ground and air transportation, lodging, meals, childcare, translation services, and doula support.
This bill allows New York pharmacists to administer FDA-approved progestin-only contraceptive injections, expanding access to this specific form of birth control. It requires pharmacists to complete training, provide patient screening questionnaires and fact sheets about clinical considerations, and notify a patient's primary care provider (unless the patient opts out). The policy directly affects patients seeking contraception and pharmacists who will administer the injections. Key safety mechanisms include mandatory screenings, provider notifications, and pharmacist discretion to refuse service if health risks are identified.